SUNNYVALE, Calif., Jan. 17, 2012 /PRNewswire/ --Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
(Photo: http://photos.prnewswire.com/prnh/20120117/MM31744 )
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
"There is compelling safety and efficacy data from multiple clinical studies that support the miraDry treatment to address excessive underarm sweat," said Dr. Michael Kaminer, managing partner of SkinCare Physicians in Chestnut Hill, Mass., and one of the physicians in the miraDry clinical trials. "Recent studies showed 90 percent efficacy and 90 percent patient satisfaction. I've seen the reduction in underarm sweat in my own patients and am excited to be able to offer this new treatment in my practice."
"We are pleased to let the millions of silent sufferers of excessive underarm sweat know that there is now a non-invasive treatment option available to them," said Darrell J. Zoromski, President and Chief Executive Officer of Miramar Labs. "One out of five people have an issue with underarm sweat and the miraDry procedure offers lasting results which can be life-changing. miraDry provides a safe and non-invasive treatment option for people to take back control of their lives without letting sweat interfere with their daily activities."
Primary axillary hyperhidrosis is a medical condition in which more underarm sweat is produced than is needed to cool the body. Millions of Americans suffer from excessive underarm sweat, and many suffer silentlyashamed, frustrated and embarrassed because excessive underarm sweat can interfere with many aspects of everyday life.
Each miraDry procedure takes approximately one hour in the doctor's office. The full treatment plan requires two procedures to maximize results. The procedure is safe and the effect can be seen almost immediately. Since the procedure is non-invasive, there is little to no downtime, so patients can go about their normal routines after treatment. The lasting result miraDry provides coupled with minimal downtime provides a significant departure from previously available alternatives which require toxins or surgical incisions.
The miraDry procedure is available in select dermatologists' offices in major metropolitan areas in the U.S. Patients can visit the www.miraDry.com website to locate a miraDry-certified physician offering the treatment or to be notified when the miraDry procedure is available in their area.
For more information, follow miraDry on Twitter @MiramarLabs, join us on Facebook at Facebook/MiramarLabs or online at www.miradry.com.
About Miramar Labs:
Founded in 2006, Miramar Labs is a privately owned medical device company dedicated to bringing the next generation energy modality to the field of dermatology. Miramar Labs is the tenth company created by The Foundry, a leading medical device incubator based in Menlo Park, California. Supported by rigorous clinical research, Miramar Labs is focused on addressing medical conditions for which there are significant unmet clinical needs. Their first priority is the treatment of excessive underarm sweat, a medical condition that significantly affects the quality of life of millions of people. The miraDry System is cleared in the United States for the treatment of primary axillary hyperhidrosis. Physicians and patients are encouraged to visit www.miradry.com for additional information about Miramar Labs.
SOURCE Miramar Labs